Andrew S. Ittleman. Courtesy photo.
A unique screening device for identifying COVID-19 biomarkers has received emergency approval from the US Food and Drug Administration with the help of Fuerst Ittleman's founding partner in Miami, Andrew S. Ittleman.
Ittleman, who said he learned the importance of building rapport and respect with the FDA when handling a public health emergency, took a year to achieve "elbow fat, communication and patience", according to Ittleman.
